文献速递妇科产科

月经周期特征与癌症发病风险:一项前瞻性队列研究

Menstrual cycle characteristics and incident cancer: a prospective cohort study.
PubMed 文献 · Hum Reprod · 2022-01-01

该前瞻性队列研究纳入护士健康研究II中78 943名无癌症史的绝经前女性,随访1989至2015年,评估不同年龄阶段月经周期规律性与长度和癌症发病风险的关系。结果显示,29-46岁月经不规律者总浸润癌风险升高11%(95%CI 2-21%),主要限于肥胖相关癌症(升高23%,95%CI 9-39%),子宫内膜癌风险最高(HR=1.39,95%CI 1.09-1.77)。

要点

  • 29-46岁月经不规律者总浸润癌风险升高11%(95%CI 2-21%)。
  • 该关联限于肥胖相关癌症,风险升高23%(95%CI 9-39%),子宫内膜癌风险最高(HR=1.39)。
  • 14-17岁月经极不规律者结直肠癌风险升高(HR=1.36,95%CI 1.02-1.81)。

核心结论

  • 育龄期月经不规律和周期过长与总浸润癌风险升高相关,尤其是肥胖相关癌症。
  • 该关联不限于妇科癌症;肥胖相关癌症可能需要被纳入长或月经不规律周期的长期健康后果谱,可能需要在中年期经历长或月经不规律周期的女性中开展针对性筛查。

研究设计与样本

  • 前瞻性队列研究,随访护士健康研究II中78 943名无癌症史的绝经前女性,随访期为1989至2015年。
  • 参与者在不同年龄阶段(14-17岁、18-22岁和29-46岁)报告月经周期通常长度和规律性,癌症诊断通过病历回顾确认。
  • 采用Cox比例风险模型估计月经周期特征与癌症发病率关联的风险比(HR)和95%CI。

主要发现

  • 随访1 646 789人年期间记录到5 794例新发癌症病例。
  • 调整BMI和其他潜在混杂因素后,29-46岁报告月经不规律的女性总浸润癌风险比同年龄报告非常规律者高11%(95%CI 2-21%)。
  • 该关联限于肥胖相关癌症,风险高23%(95%CI 9-39%),子宫内膜癌风险最高(HR=1.39;95%CI 1.09-1.77)。
  • 生命早期周期特征和月经周期长度的结果类似。
  • 14-17岁月经极不规律与结直肠癌风险显著增加相关(HR=1.36;95%CI 1.02-1.81)。

临床怎么用

  • 中年期月经不规律或周期过长的女性癌症风险统计学显著升高,尤其是肥胖相关癌症,该关联不限于妇科癌症。
  • 作者认为,肥胖相关癌症可能需要被纳入长或月经不规律周期的长期健康后果谱,可能需要在中年期经历长或月经不规律周期的女性中开展针对性筛查。

局限性

  • 青少年和成年早期月经周期特征为回顾性报告,相关发现可能存在回忆偏倚。
  • 96%的参与者为白人,对非白人女性的外推性可能有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Are menstrual cycle characteristics throughout the reproductive lifespan associated with cancer risk? SUMMARY ANSWER: Irregular and long menstrual cycles throughout the reproductive lifespan were associated with increased risk of total invasive cancer, especially obesity-related cancers. WHAT IS KNOWN ALREADY: Long and irregular menstrual cycles have been associated with lower risk of pre-menopausal breast cancer and higher risk of endometrial cancer, but associations with other malignancies are less clear. STUDY DESIGN, SIZE, DURATION: Prospective cohort study. Prospective follow-up of 78 943 women participating in the Nurses' Health Study II between 1989 and 2015. PARTICIPANTS/MATERIALS, SETTING, METHODS: We followed 78 943 pre-menopausal women without cancer history who reported the usual length and regularity of their menstrual cycles at different ages (14-17, 18-22 and 29-46 years). Cancer diagnosis was confirmed through medical record review and classified as obesity-related (colorectal, gallbladder, kidney, multiple myeloma, thyroid, pancreatic, esophageal, gastric, liver, endometrial, ovarian and post-menopausal breast) or non-obesity-related. We fitted Cox proportional hazards models to estimate hazard ratios (HRs) and 95% CIs of the association between menstrual cycle characteristics and cancer incidence. MAIN RESULTS AND THE ROLE OF CHANCE: We documented 5794 incident cancer cases during 1 646 789 person-years of follow-up. After adjusting for BMI and other potential confounders, women reporting irregular cycles at age 29-46 years had an 11% (95% CI: 2-21%) higher risk of total invasive cancer than women reporting very regular cycles at the same age. This association was limited to obesity-related cancers, with a 23% (95% CI: 9-39%) higher risk and was strongest for endometrial cancer (HR = 1.39; 95% CI: 1.09-1.77). Findings were comparable for cycle characteristics earlier in life and for menstrual cycle length. Very irregular cycles at age 14-17 years were associated with significant increase in risk of colorectal cancer (HR = 1.36; 95% CI: 1.02-1.81). LIMITATIONS, REASONS FOR CAUTION: Our study might be subject to recall bias for findings pertaining to cycle characteristics in adolescence and early adulthood, as these were retrospectively reported. Generalizability to non-White women may be limited, as 96% of participants were White. WIDER IMPLICATIONS OF THE FINDINGS: Women with irregular or long menstrual cycles in mid-adulthood had a statistically significantly higher risk of developing cancer, especially obesity-related cancers. This association was not limited to gynecological cancers. Obesity-related cancers may need to be added to the spectrum of long-term health consequences of long or irregular cycles, possibly warranting targeted screening among women who experience long or irregular cycles in mid-adulthood. STUDY FUNDING/COMPETING INTEREST: This work was supported by grants U01 CA176726, U01 HL145386 and R01 HD096033 from the National Institutes of Health. The authors have no conflicts of interest to declare. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Wang S, Wang YX, Sandoval-Insausti H, et al. Menstrual cycle characteristics and incident cancer: a prospective cohort study. Hum Reprod. 2022. PMID: 34893843. doi:10.1093/humrep/deab251

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。